Day One Biopharmaceuticals, Inc. (DAWN) Free Cash Flow by Year
Day One Biopharmaceuticals, Inc. recorded an outflow of $104.1M in free cash flow in fiscal year 2025. This represents a decrease of 29.6% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Day One Biopharmaceuticals, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
DAWN Free Cash Flow by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
DAWN Free Cash Flow by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More Day One Biopharmaceuticals, Inc. financials
Frequently Asked Questions
What was Day One Biopharmaceuticals, Inc.'s free cash flow in fiscal year 2025?
Day One Biopharmaceuticals, Inc. recorded an outflow of $104.1M in free cash flow in fiscal year 2025.
How fast is Day One Biopharmaceuticals, Inc.'s free cash flow growing?
Day One Biopharmaceuticals, Inc. (DAWN) free cash flow fell by 29.6% year over year, from -$80.3M to -$104.1M in fiscal year 2025.
How has Day One Biopharmaceuticals, Inc.'s free cash flow changed over the years?
Across the 7 fiscal years this page covers, Day One Biopharmaceuticals, Inc. (DAWN) free cash flow went from -$4.5M in fiscal year 2019 to -$104.1M in fiscal year 2025.
What was Day One Biopharmaceuticals, Inc.'s free cash flow in the most recent quarter?
Day One Biopharmaceuticals, Inc. (DAWN) reported -$14.1M in free cash flow in Q4 2025. This represents an increase of 55.0% from the same quarter a year earlier.
What does free cash flow mean on a financial statement?
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Day One Biopharmaceuticals, Inc. (DAWN) reported on that line in every period on record.